Nonmelanoma Skin Cancer
From the Journals
New guidance on preventing cutaneous SCC in solid organ transplant patients
Recommendations include cryotherapy as first-line therapy for actinic keratosis, with the exception of thin actinic keratoses grouped in one area...
From the Journals
Which AK treatment has the best long-term efficacy? A study reviews the data
The analysis “provides data that might contribute to an evidence-based framework to guide the selection of interventions for AK with proven long-...
Latest News
One in three cancer articles on social media has wrong info
Physician says misleading information online may be harmful to patients.
Latest News
Stop using Neutrogena and Aveeno spray sunscreen, J&J warns
Consumers should stop using these products and throw them away, the company said.
From the Journals
Metformin use may curb BCC risk
Population-based study shows a potential protective effect of metformin use for basal cell carcinoma, but no effect on risk of squamous cell...
News
Latest FDA pembrolizumab approval expands label to cutaneous SCCs
The objective response rate in 54 patients with locally advanced disease was 50%, including a complete response rate of 17% and a partial response...
Conference Coverage
Rate of cutaneous toxicities from ICIs may be lower than previously reported
A delay in presentation of any cutaneous immune-related adverse event after starting ICI therapy was observed (a median of 16.1 weeks), which was...
Latest News
EC approves cemiplimab for advanced or metastatic BCC after HHI therapy
Cemiplimab immunotherapy is now approved in the European Union and the United States for certain BCCs, CSCCs, and NSCLCs.
Latest News
Americans’ sun protection practices fall short of intentions
Survey suggests “that many people ... believe skin cancer won’t happen to them.”
Conference Coverage
Topical histone deacetylase inhibitor reduced BCC size in phase 2 study
At 8 weeks, there was at least a 30% decrease in diameter from baseline for 69.7% of tumors in these treated patients.
Conference Coverage
Trial yields evidence that laser resurfacing may prevent NMSC in aged skin
Three months following fractionated laser resurfacing, the ratio of AKs on treated vs. untreated arms was reduced fourfold.